544 related articles for article (PubMed ID: 6415193)
21. The evaluation of factor VIII antigen by means of a simple slide test.
Casonato A; Fabris F; Vicariotto M; Girolami A
Am J Clin Pathol; 1985 Jul; 84(1):107-11. PubMed ID: 3925753
[TBL] [Abstract][Full Text] [Related]
22. [Factor VIII (coagulation activity VIII:C, antigen concentration VIIIR:Ag and von Willebrand factor) in patients with clinically expected intravascular coagulation].
Tran TH; Lämmle B; Marbet UA; Ritz R; Marbet GA; Duckert F
Schweiz Med Wochenschr; 1981 Oct; 111(41):1542-3. PubMed ID: 6797063
[TBL] [Abstract][Full Text] [Related]
23. Gel filtration patterns of factor VIII coagulant antigen and factor VIII related antigen in normal and von Willebrand's disease.
Chediak J; Peake I; Bloom A
Thromb Haemost; 1983 Aug; 50(2):509-12. PubMed ID: 6415844
[TBL] [Abstract][Full Text] [Related]
24. [Multimeric structure of factor VIII/von Willebrand factor released from human platelets by ADP, collagen and thrombin].
López Fernández MF; Batlle Fonrodona FJ; Ginsberg MH; Ruggeri ZM; Zimmerman TS
Sangre (Barc); 1983; 28(4):439-49. PubMed ID: 6419355
[No Abstract] [Full Text] [Related]
25. Use of a simple visual assay of Willebrand factor for diagnosis and carrier identification.
Reisner HM; Katz HJ; Goldin LR; Barrow ES; Graham JB
Br J Haematol; 1978 Oct; 40(2):339-50. PubMed ID: 309339
[TBL] [Abstract][Full Text] [Related]
26. Plasma factors and platelet aggregation in diabetes mellitus.
Colwell JA; Van Zile J; Kilpatrick JM; Nair RM; Virella G
Horm Metab Res Suppl; 1981; 11():1-6. PubMed ID: 6976300
[TBL] [Abstract][Full Text] [Related]
27. Heterogeneity of sugar composition of factor VIII/von Willebrand factor in von Willebrand's disease: analysis by crossed affinoimmunoelectrophoresis using lectin (ricinus communis agglutinin-120).
Mikami S; Ueda M; Yasui M; Takahashi Y; Nishino M; Fukui H
Thromb Haemost; 1983 Apr; 49(2):87-90. PubMed ID: 6408753
[TBL] [Abstract][Full Text] [Related]
28. Failure of certain antiplatelet drugs to affect myointimal thickening following arterial endothelial injury in the rat.
Clowes AW; Karnovsky MJ
Lab Invest; 1977 Apr; 36(4):452-64. PubMed ID: 846193
[TBL] [Abstract][Full Text] [Related]
29. Immunohistological comparison of platelet factor 4 (PF4), fibronectin (Fn) and factor VIII related antigen (VIIIR:Ag) in human platelet granules.
Giddings JC; Brookes LR; Piovella F; Bloom AL
Br J Haematol; 1982 Sep; 52(1):79-88. PubMed ID: 6810914
[TBL] [Abstract][Full Text] [Related]
30. [Thrombocyte function in children with Type I diabetes mellitus. Cross-sectional study].
Nowak-Göttl U; Kreuz WD; Besier E; Grüttner HP; Krackhardt B; Breddin HK; Kornhuber B
Monatsschr Kinderheilkd; 1991 Dec; 139(12):821-5. PubMed ID: 1770958
[TBL] [Abstract][Full Text] [Related]
31. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
[TBL] [Abstract][Full Text] [Related]
32. [Von Willebrand's syndrome (author's transl)].
Larrieu MJ; Meyer D; Ardaillou N
Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):371-82. PubMed ID: 303357
[TBL] [Abstract][Full Text] [Related]
33. Relationship between plasma levels of factor VIII related antigen and reticulo-endothelial function in chronic uremia.
Milani L; Merkel C; Canel F; Gasparotto ML; Gatta A
Clin Nephrol; 1983 Nov; 20(5):235-8. PubMed ID: 6418425
[TBL] [Abstract][Full Text] [Related]
34. Plasma fibronectin, factor VIII-related antigen and fibrinogen concentrations, and diabetic retinopathy.
Davis TM; Moore JC; Turner RC
Diabete Metab; 1985 Jun; 11(3):147-51. PubMed ID: 3928410
[TBL] [Abstract][Full Text] [Related]
35. Increased platelet aggregation and fatty acid oxidation in diabetic rats.
Iida N; Iida R; Takeyama N; Tanaka T
Biochem Mol Biol Int; 1993 May; 30(1):177-85. PubMed ID: 8358330
[TBL] [Abstract][Full Text] [Related]
36. [Determination of the factor VIII ristocetin cofactor (Willebrand factor) using a semi-quantitative slide test. Preliminary results].
Bogaty-Yver J; Musitelli JJ; Conard J; Horellou MH; Samama M
Ann Biol Clin (Paris); 1983; 41(5):319-24. PubMed ID: 6421207
[TBL] [Abstract][Full Text] [Related]
37. Some immunofluorescent observations on factor VIII/von Willebrand factor in dogs.
Potter EV; Shaughnessy MA; Green D
Thromb Haemost; 1980 Oct; 44(2):56-61. PubMed ID: 6779399
[TBL] [Abstract][Full Text] [Related]
38. Factor VIII (procoagulant activity VIII:C, and antigen VIII:CAg, related antigen VIIIR:Ag and ristocetin cofactor VIIIR:Cof) in intensive care patients with clinically suspected disseminated intravascular coagulation (DIC).
Tran TH; Lämmle B; Duckert F
Am J Clin Pathol; 1984 Nov; 82(5):565-72. PubMed ID: 6437209
[TBL] [Abstract][Full Text] [Related]
39. Absent elevations in growth hormone, factor VIII related antigen, and plasminogen activator activity during exercise in diabetic patients resistant to retinopathy.
Sundkvist G; Lilja B; Almér LO
Diabetes Res; 1988 Jan; 7(1):25-30. PubMed ID: 3135976
[TBL] [Abstract][Full Text] [Related]
40. Dissociation of factor VIII procoagulant antigen VIII:CAg and factor VIII related antigen VIIIR:Ag by EDTA - influence of divalent cation on the binding of VIII:CAg and VIIIR:Ag.
Tran TH; Duckert F
Thromb Haemost; 1983 Aug; 50(2):547-51. PubMed ID: 6415848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
